ZVSA logo

ZyVersa Therapeutics (ZVSA) Net Income

Annual Net Income

-$98.30 M
-$84.25 M-599.75%

December 1, 2023


Summary


Performance

ZVSA Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherZVSAprofitabilitymetrics:

Quarterly Net Income

-$2.40 M
+$362.40 K+13.11%

September 1, 2024


Summary


Performance

ZVSA Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherZVSAprofitabilitymetrics:

TTM Net Income

-$21.33 M
+$501.10 K+2.30%

September 1, 2024


Summary


Performance

ZVSA TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherZVSAprofitabilitymetrics:

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

ZVSA Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-599.8%+15.1%+78.1%
3 y3 years-675.0%-19.8%-122.2%
5 y5 years-675.0%-19.8%-122.2%

ZVSA Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-1115.9%at low-21.9%+96.9%-454.2%+78.3%
5 y5-year-1115.9%at low-27.7%+96.9%-1034.7%+78.3%
alltimeall time-1115.9%at low-27.7%+96.9%-1034.7%+78.3%

ZyVersa Therapeutics Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$2.40 M(-13.1%)
-$21.33 M(-2.3%)
Jun 2024
-
-$2.76 M(-2.2%)
-$21.83 M(-77.6%)
Mar 2024
-
-$2.83 M(-78.8%)
-$97.58 M(-0.7%)
Dec 2023
-$98.30 M(+599.7%)
-$13.34 M(+359.6%)
-$98.30 M(+9.8%)
Sep 2023
-
-$2.90 M(-96.3%)
-$89.56 M(-0.9%)
Jun 2023
-
-$78.51 M(+2115.4%)
-$90.35 M(+552.7%)
Mar 2023
-
-$3.54 M(-23.0%)
-$13.84 M(-1.5%)
DateAnnualQuarterlyTTM
Dec 2022
-$14.05 M(+73.8%)
-$4.60 M(+24.6%)
-$14.05 M(+23.1%)
Sep 2022
-
-$3.69 M(+84.2%)
-$11.41 M(+18.9%)
Jun 2022
-
-$2.00 M(-46.5%)
-$9.60 M(+26.4%)
Mar 2022
-
-$3.75 M(+90.4%)
-$7.60 M(+97.4%)
Dec 2021
-$8.08 M(-36.3%)
-
-
Dec 2021
-
-$1.97 M(+4.7%)
-$3.85 M(+104.7%)
Sep 2021
-
-$1.88 M
-$1.88 M
Dec 2020
-$12.68 M
-
-

FAQ

  • What is ZyVersa Therapeutics annual net profit?
  • What is the all time high annual net income for ZyVersa Therapeutics?
  • What is ZyVersa Therapeutics annual net income year-on-year change?
  • What is ZyVersa Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for ZyVersa Therapeutics?
  • What is ZyVersa Therapeutics quarterly net income year-on-year change?
  • What is ZyVersa Therapeutics TTM net profit?
  • What is the all time high TTM net income for ZyVersa Therapeutics?
  • What is ZyVersa Therapeutics TTM net income year-on-year change?

What is ZyVersa Therapeutics annual net profit?

The current annual net income of ZVSA is -$98.30 M

What is the all time high annual net income for ZyVersa Therapeutics?

ZyVersa Therapeutics all-time high annual net profit is -$8.08 M

What is ZyVersa Therapeutics annual net income year-on-year change?

Over the past year, ZVSA annual net profit has changed by -$84.25 M (-599.75%)

What is ZyVersa Therapeutics quarterly net profit?

The current quarterly net income of ZVSA is -$2.40 M

What is the all time high quarterly net income for ZyVersa Therapeutics?

ZyVersa Therapeutics all-time high quarterly net profit is -$1.88 M

What is ZyVersa Therapeutics quarterly net income year-on-year change?

Over the past year, ZVSA quarterly net profit has changed by +$425.40 K (+15.05%)

What is ZyVersa Therapeutics TTM net profit?

The current TTM net income of ZVSA is -$21.33 M

What is the all time high TTM net income for ZyVersa Therapeutics?

ZyVersa Therapeutics all-time high TTM net profit is -$1.88 M

What is ZyVersa Therapeutics TTM net income year-on-year change?

Over the past year, ZVSA TTM net profit has changed by +$76.25 M (+78.14%)